Filing Details

Accession Number:
0001237648-20-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-09 15:35:36
Reporting Period:
2020-10-08
Accepted Time:
2020-10-09 15:35:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA In Vitro & In Vivo Diagnostic Substances (2835) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1570492 S. Kevin Wilson 3760 Rocky Mountain Avenue
Loveland CO 80538
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-10-08 700 $109.00 3,488 No 4 S Indirect by Daughter
Common Stock Disposition 2020-10-08 1,000 $109.00 3,086 No 4 S Indirect by Son
Common Stock Disposition 2020-10-08 683 $109.00 3,505 No 4 S Indirect by Son II
Common Stock Disposition 2020-10-08 746 $109.00 3,342 No 4 S Indirect by Son III
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Daughter
No 4 S Indirect by Son
No 4 S Indirect by Son II
No 4 S Indirect by Son III
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 72,955 Direct
Common Stock 162,763 Indirect by Cuattro, LLC
Common Stock 7,000 Indirect by Spouse
Common Stock 138,743 Indirect by Wilson Family Tr.
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 6, 2020.